The Weekly Roundup: April 8-12

To stay up-to-date with the latest dermatology news, sign up to receive our eNewsletters.

QUIZ: Test Your Knowledge of Rosacea Etiology, Types, and Triggers

Click here to read more and answer our quiz questions in recognition of Rosacea Awareness Month.

The Cutaneous Connection: Make Data-Driven Decisions For Personalized AD Treatment

Christopher Bunick, MD, PhD, delves into current data and guidelines to consider when creating custom treatment plans for patients with atopic dermatitis.

Phase 1b Data for Topical Pravibismane in Diabetic Foot Ulcer Infection Demonstrates Favorable Effects and Safety

Data was recently published in the International Wound Journal supporting positive outcomes in moderate or severe ulcers.

Springing Into the Latest Research in Dermatology

In an introduction to our April publication, explore an overview of topics covered in this issue and an introduction to our Spring Editor in Chief, Aaron Farberg, MD.

Journal Digest: April 8

This week’s collection of the latest dermatologic studies covers circulating tumor DNA in advanced cSCC, targeting IL-13 with tralokinumab in AD, a pediatric lymphoplasmocytic plaque case report, and skin of color reporting in randomized controlled trials focusing on SCC.

Rosacea Awareness Month: Resources to Share With Your Patients

This Rosacea Awareness Month, we have compiled a list of resources for clinicians to share with their rosacea patients.

Meet the Spring Editor in Chief: Aaron Farberg, MD

Dermatology Times is pleased to introduce our Spring Editor in Chief, Aaron Farberg, MD, with a snapshot of his involvement in the dermatology space.

Apremilast Demonstrates Consistent Safety and Efficacy in Children with Moderate to Severe Plaque Psoriasis at 52 Weeks

Loretta Fiorillo, MD, FRCPC, reviews key data points from the phase 3 SPROUT study.

CP-GEP Model Successful in Stratifying Node-Negative Patients into Risk Groups for Melanoma Disease Progression

According to 2 studies, this model has demonstrated the potential to assist in developing treatment and monitoring plans for early-stage melanomas.

Allergan Aesthetics Launches 2 Products For Acne-Prone Skin

Mona Gohara, MD, explained the importance of the products' impact on the skin barrier.

MoonLake Immunotherapeutics and Komodo Health to Partner to Improve Research on Inflammatory Skin Conditions

MoonLake’s sonelokimab is being evaluated for hidradenitis suppurativa, psoriasis, and psoriatic arthritis.

Fire Needle Combined With Excimer Laser Safe, Effective Therapy for Vitiligo, Review Finds

Combining fire needle therapy with a 308 nm excimer laser for vitiligo treatment, as per a recent meta-analysis, was deemed both safe and effective.

Benzene Found in Benzoyl Peroxide-Containing Acne Products: What Comes Next?

From our April cover feature: Take an in-depth look at the basis of Valisure's benzene testing methods and practical recommendations for clinicians from Christopher Bunick, MD, PhD.

Study Becomes First to Demonstrate Efficacy of Topical Isoniazid in Melasma

Study participants in the treatment group experienced an observable and significant decrease in melanin index scoring.

Shanna Miranti, MPAS, PA-C, Shares Highlights From Diversity in Dermatology Meeting

Miranti presented tips on handling denial hurdles and how to ensure patients receive access to the treatments they need.

Neurocosmetics: Sensates and Smells on the Skin

Zoe Diana Draelos, MD, provides answers to the top 5 questions about neurocosmetics patients may have.

Reflectance Confocal Microscopy Enhances Detection Sensitivity for Flat Amelanotic/Hypomelanotic Melanoma Differential Diagnosis

Diagnostic accuracy of lesions was enhanced with combined dermoscopy and reflectance confocal microscopy, according to one study.

Probiotics Cannot Replace Standard of Care Atopic Dermatitis Therapies, Research Letter Argues

In one study, researchers were unable to detect any changes in the gut microbiome of patients treated with tapering dose of steroids or a probiotic mixture.

Comparison of Psoriatic Arthritis Therapies Finds Bimekizumab More Effective Than Guselkumab

A matching-adjusted indirect comparison found that some patients with PsA are more likely to achieve long-term treatment outcomes with bimekizumab.

Rosacea Roundup: The Year so Far

This Rosacea Awareness Month, take a look at previous coverage from 2024.

Tax-Loss Harvesting: An Important Tactic Every Dermatologist Should Consider

To properly execute loss harvesting and reinvestment properly, without running afoul of Internal Revenue Service rules, it is crucial that one works with a professional adviser experienced in these matters.

Treatment With Tralokinumab Improved Epidermal Pathology, Reduced Systemic Markers In Type 2 Inflammation

Treatment also shifted the expression of key biomarkers in atopic dermatitis toward non-lesional levels, according to a recent study.

QUIZ RECAP: Test Your Knowledge of Rosacea Etiology, Types, and Triggers

Earlier this week, we shared our first Rosacea Awareness Month quiz. Review the answers and your responses below.

Surface Area of IL-23's Epitope Influences Short- and Long-Term Responses for IL-23 Inhibitors in Plaque Psoriasis

Risankizumab demonstrated the highest efficacy in PASI90 responses among analyzed IL-23 inhibitors.